इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - armodafinil - טבליה - armodafinil 50 mg - modafinil

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - armodafinil - טבליה - armodafinil 50 mg - modafinil

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - armodafinil - טבליה - armodafinil 50 mg - modafinil

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - armodafinil - טבליה - armodafinil 150 mg - modafinil

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - armodafinil - טבליה - armodafinil 150 mg - modafinil

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 500 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity.karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers. treatment of mycobacterium avium complex infection in aids patients

इसराइल - हिब्रू - Ministry of Health

abic marketing ltd, israel - efavirenz; emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - efavirenz 600 mg; emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - emtricitabine, tenofovir disoproxil and efavirenz

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 1 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 2 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - risperidone - טבליות מצופות - risperidone 3 mg - risperidone - risperidone - risperidone is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract